A NOVEL 53 KDA PROTEIN COMPLEXED WITH P210BCR-ABL IN HUMAN CHRONIC MYELOGENOUS LEUKEMIA-CELLS

被引：0
|
作者：
LI, WJ [1 ]
KLOETZER, WS [1 ]
ARLINGHAUS, RB [1 ]
机构：
[1] JOHNSON & JOHNSON BIOTECHNOL CTR INC,SAN DIEGO,CA 92121
来源：
ONCOGENE | 1988年 / 2卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：559 / 566
页数：8
相关论文
共 50 条
  • [31] p210Bcr-Abl desensitizes Cdc42 GTPase signaling for SDF-1α-directed migration in chronic myeloid leukemia cells
    Chang, Y-C
    Tien, S-C
    Tien, H-F
    Zhang, H.
    Bokoch, G. M.
    Chang, Z-F
    ONCOGENE, 2009, 28 (46) : 4105 - 4115
  • [32] P210 BCR-ABL IS COMPLEXED TO P160 BCR AND PH-P53 PROTEINS IN K562 CELLS
    CAMPBELL, ML
    LI, WJ
    ARLINGHAUS, RB
    ONCOGENE, 1990, 5 (05) : 773 - 776
  • [33] Trichosanthin down-regulated p210Bcr-Abl and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562
    Kunzhong Zhang
    Jianhua Xu
    Xiuwang Huang
    Lixian Wu
    Caixia Wen
    Yingying Hu
    Yu Su
    Yuanzhong Chen
    Zhiqiang Zhang
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 581 - 587
  • [34] Trichosanthin down-regulated p210Bcr-Abl and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562
    Zhang, Kunzhong
    Xu, Jianhua
    Huang, Xiuwang
    Wu, Lixian
    Wen, Caixia
    Hu, Yingying
    Su, Yu
    Chen, Yuanzhong
    Zhang, Zhiqiang
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (04) : 581 - 587
  • [35] Rac GTPases are critical for the development of p210-BCR/ABL-mediated chronic myelogenous leukemia (CML)
    Thomas, E. K.
    Harris, C. E.
    Druker, B. J.
    Zheng, Y.
    Cancelas, J. A.
    Williams, D. A.
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) : 52 - 52
  • [36] Chronic myeloid leukemia with p210 BCR-ABL and monocytosis
    Dass, Jasmita
    Jain, Sonal
    Tyagi, Seema
    Sazawal, Sudha
    LEUKEMIA & LYMPHOMA, 2011, 52 (07) : 1380 - 1381
  • [37] INHIBITION OF P53 IN CELLS EXPRESSING P210BCR/ABL
    LANEUVILLE, P
    BLOOD, 1993, 82 (10) : A40 - A40
  • [38] Expression of the p210BCR-ABL oncoprotein drives centrosomal hypertrophy and clonal evolution in human U937 cells
    M Giehl
    A Fabarius
    O Frank
    P Erben
    C Zheng
    M Hafner
    A Hochhaus
    R Hehlmann
    W Seifarth
    Leukemia, 2007, 21 : 1971 - 1976
  • [39] The p210BCR-ABL oncoprotein raises separase proteolytic activity in imatinib-treated cells
    Seifarth, W.
    Haass, W.
    Stehle, M.
    Giehl, M.
    Schrotz-King, P.
    Fabarius, A.
    Hofmann, W-K
    ONKOLOGIE, 2012, 35 : 189 - 189
  • [40] CONFORMATIONAL CHANGE OF P53 PROTEIN IN GROWTH FACTOR-STIMULATED HUMAN MYELOGENOUS LEUKEMIA-CELLS
    ZHANG, W
    DEISSEROTH, AB
    LEUKEMIA & LYMPHOMA, 1994, 14 (3-4) : 251 - 255
12345